Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-151919
Filing Date
2024-05-31
Accepted
2024-05-31 16:50:35
Documents
6
Effectiveness Date
2024-05-31

Document Format Files

Seq Description Document Type Size
1 S-8 d805765ds8.htm S-8 72314
2 EX-5.1 d805765dex51.htm EX-5.1 8516
3 EX-23.1 d805765dex231.htm EX-23.1 1514
4 EX-23.2 d805765dex232.htm EX-23.2 1430
5 EX-FILING FEES d805765dexfilingfees.htm EX-FILING FEES 47775
6 GRAPHIC g805765g0530082310677.jpg GRAPHIC 2142
  Complete submission text file 0001193125-24-151919.txt   135968
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279886 | Film No.: 241010535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)